Skip to main content

Table 1 The clinicopathological data of clinical tumor tissue samples

From: LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway

GroupSample numberHER2PRERAge of patientsPathological grading
TNBCHMU31500600J07(−)(−)(−)51T1N0M0 I
HMU31500574J07(−)(−)(−)73T1N0M0 I
HMU31500519J07(−)(−)(−)64T1N0M0 I
HMU31500310J07(−)(−)(−)61T1N0M0 I
HMU31500306J07(−)(−)(−)61T1N0M0 I
HMU31500294J07(−)(−)(−)52T1N0M0 I
HMU31500268J07(−)(−)(−)61T1N0M0 I
HMU31500492J07(−)(−)(−)77T2N0M0 IIA
HMU31500473J07(−)(−)(−)61T2N0M0 IIA
HMU31500376J07(−)(−)(−)40T2N0M0 IIA
HMU31500350J07(−)(−)(−)45T2N0M0 IIA
HMU31500563J07(−)(−)(−)52T2N0M0 IIA
HMU31500552J07(−)(−)(−)64T2N0M0 IIA
HMU31500529J07(−)(−)(−)65T2N0M0 IIA
HMU31500171J07(−)(−)(−)63T2N1M0 IIB
HMU31500193J07(−)(−)(−)56T2N1M0 IIB
HMU31500370J07(−)(−)(−)65T2N1M0 IIB
HMU31500213J07(−)(−)(−)43T2N1M0 IIB
HMU31500338J07(−)(−)(−)49T2N1M0 IIB
HMU31500150J07(−)(−)(−)51T2N1M0 IIB
Non-TNBCHMU31500700J07(3+)(−)(−)56T1N0M0 I
HMU31500698J07(3+)(−)(−)61T1N1M0 IIA
HMU31500636J07(3+)(−)(−)51T1N0M0 I
HMU31500710J07(3+)(−)(−)49T1N0M0 I
HMU31500731J07(3+)(−)(−)53T1N1M0 IIA
HMU31500688J07(2+)(+)(+)70T1N0M0 I
HMU31500684J07(2+)(+)(+)58T1N0M0 I
HMU31500666J07(+)(+)(+)66T1N0M0 I
HMU31500697J07(+)(+)(+)62T1N1M0 IIA
HMU31500680J07(2+)(+)(+)50T1N1M0 IIA
HMU31500702J07(−)(+)(+)43T2N1M0 IIB
HMU31500687J07(2+)(+)(+)52T2N1M0 IIB
HMU31500631J07(2+)(+)(+)50T2N1M0 IIB
HMU31500627J07(−)(+)(+)48T2N1M0 IIB
HMU31500732J07(2+)(+)(+)57T2N1M0 IIB
HMU31500755J07(3+)(+)(+)64T2N1M0 IIB
HMU31500787J07(3+)(+)(+)53T1N1M0 IIA
HMU31500884J07(−)(+)(+)44T1N1M0 IIA
HMU31500829J07(+)(+)(+)52T1N1M0 IIA
HMU31500817J07(2+)(+)(+)65T1N1M0 IIA